Article Information
History
- July 25, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Thuy P. Nguyen, MD1,#,
- Quyet Do, MD PhD2,#,
- Lan T. Phan, MD PhD3,#,
- Duc V. Dinh, MD2,#,
- Hiep Khong, PhD1,#,
- Luong V. Hoang, MD PhD2,
- Thuong V. Nguyen, MD PhD3,
- Hung N. Pham, MD PhD2,
- Men V. Chu, PharmD PhD2,
- Toan T. Nguyen, MD MSc3,
- Tri M. Le, MSc1,
- N.T. Tuyen, PharmD1,
- Thanh T. Dinh, M.Sc1,
- Thuong V. Vo, B.PH1,
- Thao T. Vu, B.PH1,
- Quynh B.P. Nguyen, PharmD1,
- Vuong T. Phan, PharmD1,
- Luong V. Nguyen, MD PhD2,
- Giang T. Nguyen, MD PhD2,
- Phong M. Tran, MD PhD2,
- Thuan D. Nghiem, MD PhD3,
- Tien V. Tran, MD PhD3,
- Tien G. Nguyen, MD PhD3,
- Tuynh Q. Tran, MD PhD2,
- Linh T. Nguyen, MD PhD2,
- Anh T. Do, MD PhD2,
- Dung D. Nguyen, MD PhD2,
- Son A. Ho, MD PhD2,
- Viet T. Nguyen, MD PhD2,
- Dung T. Pham, MD PhD2,
- Hieu B. Tran, MD Ph.D2,
- Son T. Vu, MD PhD2,
- Su X. Tran, MD PhD2,
- Trung M. Do, MD PhD2,
- Ton Tran, MD PhD3,
- Thang M. Cao, MSc3,
- Huy M. Dao, PhD3,
- Thao T.T. Nguyen, MD3,
- Uyen Y Doan, M.Sc3,
- Vy T.T. Le, PhD3,
- Linh P. Tran, M.Sc3,
- Ngoc M. Nguyen, MD3,
- Ngoc T. Nguyen, MSc3,
- Hang T.T. Pham, MSc3,
- Quan H. Nguyen, MSc3,
- Hieu T. Nguyen, BSc3,
- Hung T. Trinh, PhD4,
- Hang L.K. Nguyen, PhD5,
- Vinh T. Tran, PhD1,
- Mai T.N. Tran, PhD1,
- Truc T.T. Nguyen, MSc1,
- Phat T. Ha, MSc1,
- Hieu T. Huynh, BSc1,
- Khanh D. Nguyen, BSc1,
- Chung C. Doan, PhD1 and
- Si M. Do, Ph.D1,*
- 1Nanogen Biopharmaceuticals JSc, Lot I-5C Saigon Hitech Park, Ho Chi Minh city, Vietnam
- 2Vietnam Military Medical University, 160 Phung Hung, Ha Dong, Ha Noi, Vietnam
- 3Pasteur Institute, 167 Pasteur, District 3, Ho Chi Minh City, Vietnam
- 4Ministry of Science and Technology, Hanoi, Vietnam
- 5National Institute of Hygiene and Epidemiology (NIHE), Hanoi, Vietnam
- ↵*Corresponding author: Do Minh Si, PhD
, NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC; Lot I-5C Saigon Hitech Park, Ho Chi Minh City, Vietnam; Phone: (+84)-93-846-3579, FAX: 84-283-730-9963; Email: minhsi{at}nanogenpharma.com
↵# These authors contributed equally to this article
Posted July 25, 2021.
Safety and Immunogenicity of Nanocovax, a SARS-CoV-2 Recombinant Spike Protein Vaccine
